Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

NKTR — Nektar Therapeutics Dilution Risk Tracker

Track NKTR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NKTR — Get alerts when the score changes →

As of August 28, 2026, Nektar Therapeutics (NKTR) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Nektar Therapeutics has a market capitalization of $2.19B, 34.14M shares outstanding, 209 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $250.00M, 293.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
95
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 39%
💰 Capital Raise model 73%
• Critical: only 2.4 months cash remaining
• Active ATM program with $250M remaining capacity
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track NKTR — Get forecast alerts →

Market Data

Market Cap$2.19B
Shares Outstanding34.14M
Float21.31M
Cash$39.27M
Debt$133.50M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 58.2% shares (2026Q1 vs prior)
209 institutional holders · 31.43M shares
#1 FMR LLC 4.30M shares
#2 BVF INC/IL 2.56M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.39M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.30M
Days to Cover8.6
% of Float29.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2011-12-31
424B5 ATM 2026-04-20
4 INSIDER TRANSACTION 2026-02-20
4 INSIDER TRANSACTION 2026-02-20
424B5 ATM 2026-02-13
Full SEC filing analysis available with free account

Recent News

No recent news

Factual NKTR Dilution Snapshot

Nektar Therapeutics (NKTR) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NKTR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NKTR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NKTR
NKTR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.